SUN PHARMACEUTICAL INDUSTRIES
Back to Cashflow Statement
|
SUN PHARMACEUTICAL INDUSTRIES Last 5 Year Cash Flow from Investing Activities History
[Consolidated]
| Mar2025 | Mar2024 | Mar2023 | Mar2022 | Mar2021 | |
|---|---|---|---|---|---|
| Cash Flow from Investing Activities | ₹-5,306 Cr | ₹-690 Cr | ₹-7,944 Cr | ₹-5,725 Cr | ₹536 Cr |
What is the latest Cash Flow from Investing Activities ratio of SUN PHARMACEUTICAL INDUSTRIES ?
| Year | Cash Flow from Investing Activities |
|---|---|
| Mar2025 | ₹-5,306 Cr |
| Mar2024 | ₹-690 Cr |
| Mar2023 | ₹-7,944 Cr |
| Mar2022 | ₹-5,725 Cr |
| Mar2021 | ₹536 Cr |
How is Cash Flow from Investing Activities of SUN PHARMACEUTICAL INDUSTRIES Trending?
| Years | Cash Flow from Investing Activities | % Change | |
|---|---|---|---|
| Mar2025 | ₹-5,306 Cr | Negative | |
| Mar2024 | ₹-690 Cr | Negative | |
| Mar2023 | ₹-7,944 Cr | Negative | |
| Mar2022 | ₹-5,725 Cr | Negative | |
| Mar2021 | ₹536 Cr | - | |
Compare Cash Flow from Investing Activities of peers of SUN PHARMACEUTICAL INDUSTRIES
| Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
| SUN PHARMACEUTICAL INDUSTRIES | ₹406,609.4 Cr | 4% | -4.9% | -2.3% | Stock Analytics | |
| DIVIS LABORATORIES | ₹159,943.0 Cr | 1.1% | -9.3% | 9.1% | Stock Analytics | |
| TORRENT PHARMACEUTICALS | ₹133,336.0 Cr | -1.3% | -3.7% | 24% | Stock Analytics | |
| CIPLA | ₹107,499.0 Cr | 1.5% | -9.3% | -7.3% | Stock Analytics | |
| DR REDDYS LABORATORIES | ₹103,590.0 Cr | 5% | -0.1% | 3.3% | Stock Analytics | |
| MANKIND PHARMA | ₹85,019.3 Cr | -0.4% | -10.9% | -16.1% | Stock Analytics | |
SUN PHARMACEUTICAL INDUSTRIES Share Price vs Sensex
| Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
| SUN PHARMACEUTICAL INDUSTRIES | 4% |
-4.9% |
-2.3% |
| SENSEX | 3.5% |
-1.7% |
7.8% |
You may also like the below Video Courses